| ¿µ¹® | radiation therapy | ÇÑ±Û | ¹æ»ç¼±¿ä¹ý |
|---|---|---|---|
| ¼³¸í | X¼±, ¥ã¼±ÀÇ ÀüÀÚ¹æ»ç¼±À̳ª ÀüÀÚ¼±, ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÇ ÀÔÀÚ¹æ»ç¼±À» ÀÌ¿ëÇØ, ÁÖ·Î ¾Ç¼º Á¾¾ç Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÏ´Â Ä¡·á¹ýÀÌ´Ù. ¾Ï¼¼Æ÷°¡ ÁÖÀ§ÀÇ Á¤»ó¼¼Æ÷º¸´Ùµµ ¹æ»ç¼± °¨¼ö¼ºÀÌ ³ôÀº Á¡À» ÀÌ¿ëÇÏ¿©, Á¤»ó¼¼Æ÷ÀÇ ¼Õ»óÀ» °¡´ÉÇÑ ÇÑ ÃÖ¼Ò·Î ¾ïÁ¦ÇÏ¸é¼ ¾Ï¼¼Æ÷¸¦ ÆÄ±«ÇÑ´Ù. »ç¿ëµÇ´Â ¹æ»ç¼±¿¡´Â ¹ÐºÀ¼Ò¼±¿ø¿¡¼ ³ª¿À´Â ¥ã¼±, Á÷¼±°¡¼Ó±â¿¡¼ ¾ò¾îÁö´Â °í¿¡³ÊÁö X¼±°ú ÀüÀÚ¼±, ÅÚ·¹ÄÚ¹ßÆ®ÀåÄ¡¿¡ ÀÇÇÑ 60CoÀÇ ¥ã¼±°ú, º£Å¸Æ®·Ð¿¡ ÀÇÇÑ ÀüÀÚ¼±, »çÀÌÅ©·ÎÆ®·Ð¿¡¼ ¾ò¾îÁö´Â ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | radiation therapy | ÇÑ±Û | ¹æ»ç¼±Ä¡·á |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼±ÀÇ »ì±ÕÈ¿°ú³ª ¼¼Æ÷¸¦ Á×ÀÌ´Â È¿°ú¸¦ Ä¡·á¿¡ ÀÌ¿ëÇÏ´Â ¹æ¹ýÀ¸·Î, Á¼Àº Àǹ̷Π¾ÏÀÇ ¹æ»ç¼±Ä¡·á¸¦ ÀǹÌÇÑ´Ù. ¾Ï¿¡ ´ëÇÑ ¹æ»ç¼±Ä¡·á´Â ¾Ï¼¼Æ÷¸¦ Á×À̴µ¥ È¿°ú°¡ Å« º£Å¸¼±À» ÁÖ·Î »ç¿ëÇÑ´Ù. ÇÏÁö¸¸, ÀÌ·± ¹æ»ç¼±Ä¡·á´Â Á¤»ó¼¼Æ÷¿¡µµ Å« ¿µÇâÀ» ³¢ÃÄ ÀÌ¿¡ µû¸¥ ±â´ÉÀÇ Àå¾Ö¸¦ °¡Á®¿Ã ¼ö ÀÖ´Ù. µû¶ó¼ ¹æ»ç¼±Ä¡·á¿¡ À־ ´ÜÁö ±× ¾Ï¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ë»Ó¸¸ ¾Æ´Ï¶ó, Á¤»ó¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ëµµ °í·ÁÇÏ¿© ½ÃÇàÇÑ´Ù. |
||
| ¿µ¹® | speech therapy | ÇÑ±Û | ¾ð¾îÄ¡·á |
|---|---|---|---|
| ¼³¸í | ¸»À» Á¤È®ÇÏ°Ô ¹ßÀ½ÇÒ ¼ö ¾ø°Å³ª ´õµë´Â ȯÀÚ¿¡°Ô ¹ßÀ½, ´ëÈ µûÀ§ÀÇ ÈÆ·ÃÀ» Àü¹®ÀûÀ¸·Î ÇàÇÏ´Â Ä¡·á¹ý. |
||
| ¿µ¹® | therapy | ÇÑ±Û | ¿ä¹ý |
|---|---|---|---|
| ¼³¸í | º´À» ³´°Ô ÇÏ´Â °Í ¶Ç´Â ±× ¹æ¹ý. |
||
| ¿µ¹® | gene therapy | ÇÑ±Û | À¯ÀüÀÚ¿ä¹ý |
|---|---|---|---|
| ¼³¸í | À¯Àüº´À» Ä¡·áÇÒ ¸ñÀûÀ¸·Î, Á¤»óÀûÀ¸·Î ±â´ÉÇÏ´Â ´ÜÀÏÀ¯ÀüÀÚ È¤Àº º¹¼öÀ¯ÀüÀÚ¸¦ ¾î¶² ±â¿ø¿¡¼ ¾ò¾î³»¾î »ý¼¼Æ÷¿¡ µµÀÔÇÏ´Â °Í. À¯Àü¹°ÁúÀº À¯ÀüÀÚ»ðÀÔ Á¶ÀÛ¿¡ ÀÇÇØ ¼ö¿ë¼¼Æ÷¿¡·Î µµÀԵȴÙ. Áï, À¯ÀüÀÚ¸¦ ³¢¿ö ³ÖÀº »õ·Î¿î ¼¼Æ÷¸¦ »ç¿ëÇÏ´Â Ä¡·á·Î¼ 1980³â ¹Ì±¹ÀÇ ÇÐÀÚ°¡ ÁöÁßÇØºóÇ÷ȯÀÚ¿¡°Ô °ÇàÇÏ¿© ºñÆÇÀ» ¹Þ¾ÒÁö¸¸, ¹Ì±¹ ±¹¸³º¸°Ç¿¬±¸¼Ò´Â 1990³â 9¿ù ¾Æµ¥³ë½Å µ¥¾Æ¹Ì³ª¾ÆÁ¦(adenosine deaminase, ADA) °áÇÌÁõ ȯÀÚÀÇ ¸²ÇÁ±¸¿¡ ADA À¯ÀüÀÚ¸¦ ³¢¿ö ³Ö´Â Ä¡·á¸¦ ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç´Â ¾ÏÀ» Æ÷ÇÔÇÑ ¸¹Àº Áúº´µéÀ» Ä¡·áÇÏ´Â ¸ñÀûÀ¸·Î ¾²ÀδÙ. |
||
| EDR | early diastolic relaxation; effective direct radiation; electrodermal response |
|---|---|
| GT | gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm... |
| RT | radiologic technologist; radiotelemetry; radiotherapy; radium therapy; rapid tranquilization; reacti... |
| SAT | saliva alcohol test; satellite; serum antitrypsin; single-agent chemotherapy; slide agglutination te... |
| ISA | Instrument Society of America; intracarotid sodium amytal; intrinsic simulating activity; intrinsic ... |
| structure activity analysis | Study in which systematic variation in the structure of a compound is correlated with its activity, in an attempt to determine the characteristics of the (receptor) site at which it acts. (18 Nov 1997) |
|---|---|
| structure-activity relationship | The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Other factors contributing to structure-activity relationship include chemical reactivity, electronic effects, resonance, and inductive effects. (12 Dec 1998) |
| nonsuppressible insulin-like activity | A blood protein (nsila) which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of cohn fraction III, 10% of the activity is found in the supernatant (nsila-s) and the remaining activity in the precipitate (nsila-p). The latter is a large molecular compound, much less stable than the soluble fraction. Nsila-s is a more potent growth factor than insulin and exhibits sulfation activity. (12 Dec 1998) |
| drug activity | A measure of the physiological response a drug produces. A less active drug produces less response (and visa versa). (12 Dec 1998) |
| insulin-like activity | A measure of substances, usually in plasma, that exert biologic effects similar to those of insulin in various bioassays; sometimes used as a measure of plasma insulin concentrations; always gives higher values than immunochemical techniques for the measurement of insulin. (05 Mar 2000) |
| intrinsic sympathomimetic activity | The property of a drug that causes activation of adrenergic receptors so as to produce effects similar to stimulation of the sympathetic nervous system. (05 Mar 2000) |
| optical activity | The ability of a material to rotate the plane of polarized light. (09 Oct 1997) |
| triggered activity | One or a series of spontaneously generated heart beats originating from an action potential that produces an after-depolarisation which reaches activation threshold. (05 Mar 2000) |
| unit of thyrotrophic activity | The activity of an amount of an extract of the anterior lobe of the hypophysis which, given daily for 5 days, will cause the thyroid of a guinea pig (weighing 200 g) to reach a weight of 600 mg. (05 Mar 2000) |
| zone of polarizing activity | <cell biology> The small group of mesenchyme cells in avian limb buds that is located at the posterior margin of the developing bud and that produces a substance, possibly retinoic acid, that provides positional information to the developing limb bud. (18 Nov 1997) |
| acupuncture therapy | Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. Heat or moxibustion and acupressure may be used in conjunction. (12 Dec 1998) |
| adjuvant therapy | <oncology, pharmacology> Treatment that is added to increase the effectiveness of a primary treatment. In cancer, adjuvant treatment usually refers to chemotherapy, hormonal therapy or radiation therapy after surgery to increase the likelihood of killing all cancer cells. (14 May 1997) |
| alternative therapy | A term given to nonconventional therapy usually given by persons who do not have a medical qualification. (16 Dec 1997) |
| analytic therapy | Short term for psychoanalytic therapy. (05 Mar 2000) |
| Antibody Directed Enzyme Prodrug Therapy | <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately. The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects. Acronym: ADEPT (14 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|